News Focus
News Focus
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: biopharm post# 246831

Sunday, 12/27/2015 11:57:10 AM

Sunday, December 27, 2015 11:57:10 AM

Post# of 347009
biopharm, I like this post. Apart from what all the trued(s) are of what happened with PPHM's stock, clinical trials sabotages and organized eMagazine and Twitter actions to hinder the company, it emphasises that more then normal things have been happening.

And in my experience when more then normal things happen and they become so obvious and actually consistent in nature then this is always because of MONEY.

The results of 1st and 2nd ln NSCLC, Pancreatic and possibly with hindsight HCV all suffering from a defect the makes the trial results worthless, or if failed could have made it worthless, is TO MUCH for one company.

What the roles are of BMY, Ayer, Piper Jaffray's but also AF, PC, West, Schwartz, Finken, Bleecker, etc in all that we may possibly never know. But one thing we do know, coincidence or not, is that if it WASN'T orchestrated then at least it sounded like a well rehearsed requiem.

But this "Missa pro Defunctis" was a little premature and resulted in the resurrection of PPHM, in better shape then it has ever been in its complete existance :)

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y